ReviewCurrent cardiology reports2025

Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis.

Johannes Bernhard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.